Low-intensity laser treatment doesn't prevent vision loss from age-related macular degeneration, a study of U.S. eye centers showed.
The study by the U.S. National Eye Institute in Bethesda, Md., showed the treatment did not stop -- or even slow down -- AMD-related vision loss, WebMD.com said. Paul A. Sieving, institute director, said doctors should reconsider using this treatment.
Age-related macular degeneration is the leading cause of vision loss in the United States, WebMD.com said. Warning signs include deposits called drusen under the retina. For years, ophthalmologists tried to prevent AMD-related vision loss by blasting drusen with low-intensity lasers.
The trial enrolled 1,052 people with drusen deposits in each eye, WebMD.com said. The patients were treated by laser in one eye but not the other. Five years later, researchers found no difference in vision between the two eyes.
The research found that while the treatment didn't stop AMD-related vision loss, it didn't cause any harm, either, WebMD.com said.
Results of the study are in the November issue of Ophthalmology.
Copyright 2006 by United Press International
Related stories:
Elderly falls cut by 11 percent with education and intervention
Commonly viewed as an inevitable consequence of aging and often ignored in clinical practice, falls among the elderly were cut by 11 percent when researchers at Yale School of Medicine used a combination of fall prevention educational campaigns and interventions aimed at encouraging clinicians to incorporate fall-risk assessment and management into their practices.
Protein transports nutrients believed to protect against eye disease
Scientists have identified the protein responsible for transporting nutrients to the eye that are believed to protect against the development of age-related macular degeneration, a leading cause of vision loss in elderly Americans.
Balance problems? Step into the iShoe
(PhysOrg.com) -- Your grandmother might have little in common with an astronaut, but both could benefit from a new device an MIT graduate student is designing to test balancing ability.
Corneal transplant technique shows promise in children
For infants and children with blinding diseases of the cornea, a sophisticated new corneal transplantation technique offers the hope of improving vision while overcoming the technical difficulty and low success rate of traditional penetrating keratoplasty (PK) in children, according to reports in the current issue of the
Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).
Retina transplants show promise in patients with retinal degeneration
Preliminary research shows encouraging results with transplantation of retinal cells in patients with blindness caused by retinitis pigmentosa (RP) and age-related macular degeneration (AMD), according to a report in the August issue of
American Journal of Ophthalmology.
Glaucoma surgery studied in medicare patients, new hope for people
Ophthalmologists (Eye M.D.s) continue to develop treatments to help the more than three million Americans with glaucoma. The July issue of
Ophthalmology includes a large, national study of outcomes of incisional surgeries, used to reduce pressure inside the eye, in Medicare patients. Also covered is research that may brighten the outlook for patients with end-stage glaucoma.
Wake up and smell the coffee: Study finds that caffeine may help prevent MS
A good cup of coffee might be just the wake-up call scientists need to stop multiple sclerosis.
Portable device effective in zapping away migraine pain
novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.